ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

European Diabetology

European Diabetology is an active company incorporated on 15 August 2013 with the registered office located in Bristol, Bristol. European Diabetology was registered 12 years ago.
Status
Active
Active since incorporation
Company No
08652560
Private Limited Company by guarantee without share capital, use of 'Limited' exemption
Age
12 years
Incorporated 15 August 2013
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 15 August 2025 (2 months ago)
Next confirmation dated 15 August 2026
Due by 29 August 2026 (10 months remaining)
Last change occurred 9 years ago
Accounts
Submitted
For period 1 Sep31 Aug 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 August 2025
Due by 31 May 2026 (7 months remaining)
Address
Rsm, 2nd Floor One The Square
Temple Quay
Bristol
BS1 6DG
United Kingdom
Address changed on 23 May 2022 (3 years ago)
Previous address was Hartwell House 55-61 Victoria Street Bristol BS1 6AD
Telephone
Unreported
Email
Available in Endole App
People
Officers
11
Shareholders
-
Controllers (PSC)
1
Director • Director • Patient Advocate • British • Lives in Scotland • Born in Aug 1989
Director • Academic Researcher • British • Lives in UK • Born in May 1966
Director • Professor Of Diabetic Medicine • British • Lives in Scotland • Born in Jul 1972
Director • Associate Professor • Dutch • Lives in Netherlands • Born in Sep 1982
Director • Professor Of Molecular Diabetology/ Director • Italian • Lives in Germany • Born in Nov 1960
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Ceehealth Ltd
Emma Jane Doble is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Aug 2024
For period 31 Aug31 Aug 2024
Traded for 12 months
Cash in Bank
£1.12M
Increased by £185.63K (+20%)
Turnover
£579.42K
Decreased by £123.29K (-18%)
Employees
Unreported
Same as previous period
Total Assets
£1.68M
Increased by £242.57K (+17%)
Total Liabilities
-£166.86K
Decreased by £101.91K (-38%)
Net Assets
£1.51M
Increased by £344.48K (+29%)
Debt Ratio (%)
10%
Decreased by 8.75% (-47%)
Latest Activity
Professor Michele Solimena Appointed
1 Month Ago on 1 Sep 2025
Mrs Emma Jane Doble Appointed
1 Month Ago on 1 Sep 2025
Confirmation Submitted
2 Months Ago on 15 Aug 2025
Dr Ruth Loos Details Changed
2 Months Ago on 8 Aug 2025
Ms Michelle Louise Harris Details Changed
4 Months Ago on 1 Jun 2025
Full Accounts Submitted
5 Months Ago on 2 May 2025
Kathleen Gillespie Resigned
8 Months Ago on 28 Feb 2025
Professor Maciej Małecki Appointed
8 Months Ago on 4 Feb 2025
Dr Femke Rutters Appointed
1 Year 1 Month Ago on 18 Sep 2024
Confirmation Submitted
1 Year 2 Months Ago on 28 Aug 2024
Get Credit Report
Discover European Diabetology's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Appointment of Professor Michele Solimena as a director on 1 September 2025
Submitted on 2 Sep 2025
Appointment of Mrs Emma Jane Doble as a director on 1 September 2025
Submitted on 1 Sep 2025
Confirmation statement made on 15 August 2025 with no updates
Submitted on 15 Aug 2025
Director's details changed for Dr Ruth Loos on 8 August 2025
Submitted on 8 Aug 2025
Secretary's details changed for Ms Michelle Louise Harris on 1 June 2025
Submitted on 10 Jun 2025
Termination of appointment of Kathleen Gillespie as a director on 28 February 2025
Submitted on 13 May 2025
Total exemption full accounts made up to 31 August 2024
Submitted on 2 May 2025
Appointment of Professor Maciej Małecki as a director on 4 February 2025
Submitted on 11 Feb 2025
Appointment of Dr Femke Rutters as a director on 18 September 2024
Submitted on 24 Sep 2024
Confirmation statement made on 15 August 2024 with no updates
Submitted on 28 Aug 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year